Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Boris Arbit"'
Autor:
S. William Tam, Neil Beri, Alan S. Maisel, Boris Arbit, Sutton Fox, Kay Won Chang, Jay N. Cohn, Paul Clopton, Nghia Nguyen, Sean Mojaver, Inder S. Anand, Anne L. Taylor
Publikováno v:
Journal of Cardiac Failure. 24:303-309
Recent studies have described the entity of heart failure with recovered ejection fraction (HFrecEF), but population-specific studies remain lacking. The aim of this study was to characterize patients enrolled in the African-American Heart Failure Tr
Autor:
Nick Marston, Elizabeth Lee, Boris Arbit, Hermineh Aramin, Paul Clopton, Alan S. Maisel, Kevin S. Shah
Publikováno v:
The American Journal of Cardiology. 117:1310-1314
Patients with heart failure have a poor prognosis, yet outcomes might be improved by early identification of risk. Proenkephalin (proENK), a novel biomarker, is a stable surrogate marker for endogenous enkephalins and is an independent predictor of h
Autor:
Boris Arbit, Jonathan C. Hsu
Publikováno v:
Clinical Cardiology. 38:684-691
Atrial fibrillation (AF) is the most common cardiac arrhythmia and predisposes patients to an increased risk of embolic stroke. After nearly 60 years, warfarin is no longer the only effective therapeutic option for patients with AF. Large randomized
Publikováno v:
International journal of cardiology. 243
Atrial fibrillation and coronary artery disease are common comorbidities with increasing incidences worldwide. About 5-15% of atrial fibrillation patients will require coronary stenting at some point in their lives, which necessitates dual antiplatel
Autor:
Jon Kobashigawa, Raj Makkar, Amelia Young, Babak Azarbal, B S Matthew Rafiei, Michelle M. Kittleson, Lawrence Czer, Boris Arbit, Radhakrishnan Ramaraj, Jesse Currier
Publikováno v:
Journal of Interventional Cardiology. 27:73-79
Objectives: This study aimed to examine clinical efficacy, safety, and intermediate clinical outcomes with everolimus‐eluting stents (EESs) in patients with transplant coronary artery disease (TCAD). Background: TCAD is a major cause of mortality i
Publikováno v:
International journal of cardiology. 223
For several decades the vitamin K antagonist oral anticoagulants were the only outpatient therapy that existed to reduce the risk of stroke and thromboembolism. When the new direct oral anticoagulants were approved for use and addressed many of the i
Autor:
Boris, Arbit
Publikováno v:
Journal of the American College of Cardiology. 67(21)
Publikováno v:
Current opinion in cardiology. 31(2)
Purpose of review Natriuretic peptides, high-sensitivity cardiac troponins, and suppression of tumorigenicity 2 are novel biomarkers that reflect the intricate pathophysiology of heart failure and can thus be used for the diagnosis, management, and p
Publikováno v:
Cardiac Biomarkers ISBN: 9783319429809
Research over the last 20 years has led to a new understanding of the central role of mitochondrial function in the physiology of aging and the pathogenesis of cardiovascular diseases. Sarcopenia, the gradual loss of skeletal muscle mass, is the most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b897ef2fecbdd113b29cb406d2595e22
https://doi.org/10.1007/978-3-319-42982-3_25
https://doi.org/10.1007/978-3-319-42982-3_25
Publikováno v:
Acta Cardiologica. 66:807-810
Swine-origin influenza A (H1N1) virus was identified in March of 2009 in Mexico and the United States. The virus spread rapidly, becoming pandemic by June. Previous studies examined the role of influenza infection in cardiovascular disease, however,